Related Experiment Video
Updated: Mar 8, 2026

11:33
Fabrication of Three-dimensional Paper-based Microfluidic Devices for Immunoassays
Published on: March 9, 2017
16.5K
A simple method to produce 2D and 3D microfluidic paper-based analytical devices for clinical analysis
Ricardo A G de Oliveira1, Fiamma Camargo1, Naira C Pesquero2
1Departamento de Química, Universidade Federal de São Carlos, São Carlos, SP, 13565-905, Brazil.
Analytica Chimica Acta
|January 22, 2017
Summary
Researchers developed novel 2D and 3D microfluidic paper-based analytical devices (μPADs) for detecting glucose, protein, and nitrite. This fabrication method offers a low-cost, precise approach for point-of-care diagnostics.
Area of Science:
- Analytical Chemistry
- Biomedical Engineering
- Materials Science
Background:
- Microfluidic paper-based analytical devices (μPADs) offer a promising platform for low-cost diagnostics.
- Accurate and sensitive detection of biomarkers like glucose, total protein, and nitrite is crucial for health monitoring.
Purpose of the Study:
- To fabricate and evaluate novel 2D and 3D microfluidic paper-based analytical devices (μPADs).
- To establish a new, cost-effective method for μPAD fabrication using filter paper.
- To assess the analytical performance of these μPADs for detecting glucose, total protein, and nitrite in biological fluid samples.
Main Methods:
- Development of a novel cutting and sealing technique for cellulose-based filter paper to create hydrophilic microchannels.
- Design of 2D and 3D μPADs with three distinct detection zones for colorimetric analysis.
- Sample application, 15-minute incubation, and digital camera imaging for quantitative analysis.
Main Results:
- Both 2D and 3D μPADs demonstrated excellent analytical performance for all target analytes.
- The 2D μPAD achieved limits of detection (LODs) of 0.54 mM (glucose), 5.19 μM (protein), and 2.34 μM (nitrite) in artificial urine.
- The 3D μPAD achieved LODs of 0.44 mM (glucose), 1.26 μM (protein), and 4.35 μM (nitrite) in artificial blood serum.
Conclusions:
- The developed fabrication method enables precise and easy production of 2D and 3D μPADs.
- These μPADs provide a sensitive and reliable platform for the simultaneous detection of glucose, total protein, and nitrite.
- The findings highlight the potential of these μPADs for accessible point-of-care diagnostic applications.

